HITI · High Tide Inc. · Metrics
$2.69
+0.02 (+0.75%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$238.01M
Shares
89.14M
Volume · Oct 28
284.58K
Avg daily vol (3M)
591.78K
HITI metrics
56 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$2.69
Market cap
$238.01M
Price action
20 metricsPrice change (1W)
+0.8%
Price change (30D)
-5.0%
Price change (3M)
+29.6%
Price change (6M)
+6.4%
Price change (YTD)
+0.8%
Price change (1Y)
-17.8%
Trailing year
Price change (5Y)
-51.1%
52-week high
$3.25
52-week low
$2.05
Change from 52-week high
-17.8%
Change from 52-week low
+30.2%
Annualized volatility
42.5%
Annualized volatility (3M)
37.6%
Beta
0.9
RSI (14D)
53.9
Price vs SMA 50
+2.4%
Price vs SMA 200
+10.2%
Avg volume (3M)
597,105
Relative volume
0.5
Average dollar volume
$1.53M
Company
3 metricsSector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
89.14M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
3.8
reciprocal yield 26.3%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-09-15
Profitability
9 metricsGross margin
25.8%
Operating margin
-2.4%
Trailing 12 months
Net margin
-8.5%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+13.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+8.0%
Year over year · more shares
Revenue CAGR (3Y)
+18.5%
Revenue CAGR (5Y)
+48.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
+16.0%
Quality
14 metricsReturn on equity
-57.9%
Return on assets
-14.5%
Debt / equity
0.7
Current ratio
1.4
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$8.63M
Latest balance sheet
Cash & equivalents
$34.18M
Total assets
$249.15M
Total debt
$42.86M
Cash flow & spend
7 metricsOperating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
9 metrics13F filers
50
13F filer change QoQ
-2
Institutional ownership
8.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-14.7%
Holder tenure
10.5
Price vs estimated holder cost
-14.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
1.9%
Short interest
3 metricsShort interest
1.0%
Latest settlement · 1.7 days to cover
Days to cover
1.7d
Short-squeeze score
53 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1847409
CUSIP
42981E401
13F (30d)
10 filings
10 filers
Visit website
Investor relations